Comunicación Nº: 056 | English version |
Marco Masseroli, Francisco O'Valle, Trinidad Caballero,
Alejandro Pérez Milena, Raimundo M.G. Del Moral,
Raimundo G. Del Moral.
[Título] [Introducción] [Material y Métodos] [Resultados] [Iconografía] [Discusión]
1.- Popper H, Piez KA. Collagen metabolism in the liver. Am J Dig Dis 1978;23(7):641-659.
2.- Rojkind M, Giambrone MA, Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology 1979;76(4):710-719.
3.- Rojkind M, Kershenobich D. Hepatic fibrosis. Clin Gastroenterol 1981;10:737-754.
4.- Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. HEPATOLOGY 1994;19(6):1513-1520.
5.- Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOLOGY 1981;1:431-435.
6.- Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-374.
7.- Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 1993;105:274-278.
8.- Theodossi A, Skene AM, Portmann B, Knill-Jones RP, Patrick RS, Tate RA, Kealey W, et al. Observer variation in assessment of liver biopsies including analysis by kappa statistics. Gastroenterology 1980;79(2):232-241.
9.- Rubio CA, Porwit A. Quantitation of fibrosis in liver biopsies. Anal Quant Cytol Histol 1988;10(2):107-109.
10.- Tarao K, Hoshino H, Motohashi I, Iimori K, Tamai S, Ito Y, Takagi S, et al. Changes in liver and spleen volume in alcoholic liver fibrosis of man. HEPATOLOGY 1989;9(4):589-593.
11.- Manabe N, Chevallier M, Chossegros P, Causse X, Guerret S, Trépo C, Grimaud J-A. Interferon-a2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation. HEPATOLOGY 1993;18(6):1344-1349.
12.- Nohlgard C, Rubio CA, Kock Y, Hammar H. Liver fibrosis quantified by image analysis in methotrexate-treated patients with psoriasis. J Am Acad Dermatol 1993;28(1):40-45.
13.- Shimamatsu K, Kage M, Nakashima O, Kojiro M. Pathomorphological study of HCV antibody-positive liver cirrhosis. J Gastroenterol Hepatol 1994;9(6):624-630.
14.- Nakabayashi H, Takamatsu S, Tsujii H, Okamoto Y, Nakano H, Yamada E, Ichijima K. Collagen content of liver biopsy specimens in patients with chronic hepatitis. Intern Hepatol Comm 1996;4(6):311 315.
15.- Pilette C, Rousselet MC, Bedossa P, Chappard D, Oberti F, Maiga M, Gallois Y, et al. Histological evaluation of liver fibrosis: observer score or image analysis?. HEPATOLOGY 1995;22(4):475A.
16.- Sweat F, Puchtler H, Rosenthal SI. Sirius red F3BA as a stain for connective tissue. Arch Pathol 1964;78:69-72.
17.- Gonzales RC, Woods RE. Digital image processing. Reading, MA: Addison-Wesley Publishing Company, 1992.
18.- Kurita T, Otsu N, Abdelmalek N. Maximum likelihood thresholding based on population mixture models. Pattern Recognition 1992;25(10):1231-1240.
19.- Serra J. Image analysis and mathematical morphology. London, UK: Academic Press, 1982.
20.- Serra J. Image analysis and mathematical morphology: theorical advances. London, UK: Academic Press, 1988.
21.- Kittler J, Illingworth J. Minimum error thresholding. Pattern Recognition 1986;19(1):41-47.
22.- López De Leon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 1985;33(8):737-743.
23.- Jimenez W, Parés A, Caballería J, Heredia D, Bruguera M, Torres M, Rojkind M, Rodés J. Measurement of fibrosis in needle liver biopsies: evaluation of a colorimetric method. HEPATOLOGY 1985;5(5):815-818.
24.- Malkusch W, Rehn B, Bruch J. Advantages of Sirius red staining for quantitative morphometric collagen measurements in lungs. Exp Lung Res 1995;21(1):67-77.